Monday, September 10, 2018 11:20:01 AM
Meeting times with representatives are available pre and post Plenary times.
Contact:
David Donlin
Cervelle Group
407-490-6635
http://2018usca.org/
@NMACCommunity @USCA_NMAC $IMUN
3:29 PM - 6 Sep 2018
Immune Therapeutics in attendance at the 2018 United States Conference on AIDS (USCA).
— Immune Therapeutics (@ImmuneLDN) September 6, 2018
Meeting times with representatives are available pre and post Plenary times.
Contact:
David Donlin
Cervelle Group
407-490-6635https://t.co/f3c0DzhPqm@NMACCommunity @USCA_NMAC $IMUN
$IMUN
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM